TLR8 and neoplasm: Conversely, introduction an antisense targeting 5′‐half‐GlyGCC to tumour Te‐EVs abrogated p65 phosphorylation and reduced TNF‐α and IL‐6 secretion in dTHP‐1 cells via TLR8 (Figure S12C,D).